牛牛AI助理已提取核心訊息
Kathryn E. Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, completed a stock transaction on February 13, 2024. Wengel executed a sale of 333 shares of Johnson & Johnson common stock at a price of $157.85 per share, resulting in a total transaction value of $52,564.05. Additionally, Wengel acquired 651 shares through the exercise of derivative securities at no cost. Following these transactions, Wengel's direct holdings in the company amounted to 82,265.8735 shares. The transactions were part of Wengel's planned financial activities and were reported in compliance with regulatory requirements.
Kathryn E. Wengel, EVP, Chief TO and Risk Officer at Johnson & Johnson, completed a stock transaction on February 13, 2024. Wengel executed a sale of 333 shares of Johnson & Johnson common stock at a price of $157.85 per share, resulting in a total transaction value of $52,564.05. Additionally, Wengel acquired 651 shares through the exercise of derivative securities at no cost. Following these transactions, Wengel's direct holdings in the company amounted to 82,265.8735 shares. The transactions were part of Wengel's planned financial activities and were reported in compliance with regulatory requirements.
強生公司執行副總裁、首席技術官兼風險官凱瑟琳·溫格爾於2024年2月13日完成了一筆股票交易。溫格爾以每股157.85美元的價格出售了333股強生普通股，交易總額爲52,564.05美元。此外，溫格爾通過行使衍生證券免費收購了651股股票。這些交易之後，溫格爾在該公司的直接持股量爲82,265.8735股。這些交易是溫格爾計劃財務活動的一部分，是根據監管要求進行報告的。
強生公司執行副總裁、首席技術官兼風險官凱瑟琳·溫格爾於2024年2月13日完成了一筆股票交易。溫格爾以每股157.85美元的價格出售了333股強生普通股，交易總額爲52,564.05美元。此外，溫格爾通過行使衍生證券免費收購了651股股票。這些交易之後，溫格爾在該公司的直接持股量爲82,265.8735股。這些交易是溫格爾計劃財務活動的一部分，是根據監管要求進行報告的。
有用
沒用